VX-24
E1409176
UNEXPLORED
VX-24 is a U.S. Navy air test and evaluation squadron responsible for testing and assessing naval aircraft systems and weapons.
All labels observed (1)
| Label | Occurrences |
|---|---|
| VX-24 canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T20045655 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: VX-24 Context triple: [Air Test and Evaluation Squadron 24, abbreviation, VX-24]
-
A.
VX-264
VX-264 is an investigational therapy being developed by Vertex Pharmaceuticals, likely targeting a serious disease area such as cystic fibrosis or another genetic condition within the company’s clinical pipeline.
-
B.
VX-548
VX-548 is an investigational non-opioid pain medication developed by Vertex Pharmaceuticals that targets NaV1.8 sodium channels to treat acute and chronic pain.
-
C.
VX-31
VX-31 is a United States Navy air test and evaluation squadron responsible for testing and assessing the performance of naval aircraft and related systems.
-
D.
VX
VX is the IATA airline designator used for the former U.S.-based low-cost carrier Virgin America.
-
E.
VX-880
VX-880 is an investigational cell-based therapy being developed by Vertex Pharmaceuticals for the treatment of type 1 diabetes by replacing lost insulin-producing beta cells.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: VX-24 Target entity description: VX-24 is a U.S. Navy air test and evaluation squadron responsible for testing and assessing naval aircraft systems and weapons.
-
A.
VX-264
VX-264 is an investigational therapy being developed by Vertex Pharmaceuticals, likely targeting a serious disease area such as cystic fibrosis or another genetic condition within the company’s clinical pipeline.
-
B.
VX-548
VX-548 is an investigational non-opioid pain medication developed by Vertex Pharmaceuticals that targets NaV1.8 sodium channels to treat acute and chronic pain.
-
C.
VX-31
VX-31 is a United States Navy air test and evaluation squadron responsible for testing and assessing the performance of naval aircraft and related systems.
-
D.
VX
VX is the IATA airline designator used for the former U.S.-based low-cost carrier Virgin America.
-
E.
VX-880
VX-880 is an investigational cell-based therapy being developed by Vertex Pharmaceuticals for the treatment of type 1 diabetes by replacing lost insulin-producing beta cells.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.